Follicular lymphoma trials in Austria

3 of 5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  Where

  Linz, Salzburg, Vienna

  Age

  18 years and over

  People

  822 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT06091254 · EU 2022-502660-20-00
• Phase 3Active, not recruiting
  A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  Where

  Linz, Vienna, Wels

  Age

  18 years and over

  People

  580 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT06149286 · EU 2022-503092-28-00
• Phase 2Taking people
  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Where

  Graz, Innsbruck, Linz, Vienna

  Age

  18 years to 70 years

  People

  213 worldwide

  Run by

  Miltenyi Biomedicine GmbH

  See details and how to joinNCT04844866 · EU 2023-506270-13-00